EDVA

Endovia Health Sciences, Inc.

$0.17

-7.15%

SectorHealthcareIndustryBiotechnologyCountryUnited States

Overview AI Brief ChartChart & Performance Financials ExposureRevenue Exposure FilingsFilings & Red Flags ScoresScores & Valuation News Analysts InsidersInsiders & Short Interest Ownership

Endovia Health Sciences, Inc. develops a diversified cannabinoid health sciences platform that translates science into regulated therapies and trusted health and wellness products for people and animals in Ireland, United Kingdom, Australia, and Latin America. Its product includes CannEpil a pharmaceutical-grade cannabinoid formulation comprising cannabidiol and tetrahydrocannabinol isolates in an oral liquid solution. Endovia Health Sciences, Inc. formerly known as Splash Beverage Group, Inc. The company is based in Fort Lauderdale, Florida.

Source: Yahoo Finance

Market Cap$1.9M

Dividend Yield0.00%

Beta-1.15

AI summary

Price & performance

1M-22.0%

3M-57.4%

YTD-94.6%

1Y-98.0%

52-week range—

Beta-1.15

Full chart and returns against a benchmark

Q-Score

14/ 100

Quality against peers; 50 is the peer median.

Growth23

Risk27

Performance20

Valuation4

Profitability43

Leverage7

Sentiment—

Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$73.1K-90.9%

Net income-$25.2M

Net margin—

Historical fundamentals

Red flags in filings

4active red flags

Going-concern doubtApr 15, 2026

Material weakness in controlsApr 15, 2026

Late filing noticeAug 17, 2026

Filings, findings and the timeline

Revenue exposure

0%of revenue from outside the US

United States100%

Regions, segments, customers and suppliers

Valuation

EDVAIndustryP/E—89.69P/S60.4611.88EV/EBITDA—67.10P/B—6.22PEG—4.02

Dividend yield0.00%

Every valuation metric

Historical Fundamentals

Revenue

Net Income

Net Margin

Showing the last 4 periods. Pro adds the full annual and quarterly history and 20+ more metrics to chart.

Latest Results

The latest fiscal year and quarter, each against the same period a year earlier, from SEC filings.

Metric	FY 2025	vs a year before	Q2 2026	vs a year before
Revenue	$73.1K	-90.9%	$0.00	—
Net Income	-$25.2M	—	-$2.1M	—

Q-Scores

OverallCombines the categories below, except Sentiment

Industry 5714

Growth

Industry 7923

Risk

Industry 5527

Performance

Industry 6620

Valuation

Industry 254

Profitability

Industry 4743

Leverage

Industry 687

Key Metrics

Fundamentals: trailing twelve months to Jun 2026, from the latest 10-K and 10-Qs.

Market Beta (5-factor)

IM 0.72SM 0.780.35

Market Cap

1.9M

Dividend Yield

IM 0.00%SM 0.00%0.00%

Volume

IM 693.1KSM 741.7K3.4M

Industry Market Share

0.00%

Sector Market Share

0.00%

IM industry median · SM sector median: the typical company the value is compared with. The /100 is its score against those peers.

Comparable Companies

The companies closest in size in Biotechnology (filled from its sector when there are few), with the median and rank across all 571 in the industry.

Company	Market cap	P/E	P/S	P/B	FCF yield	Revenue growth	Op. margin	ROE	Debt/equity
EDVAEndovia Health Sciences, Inc.	$1.9M	—	60.5	—	-282.6%	—	—	—	—
ONCOOnconetix, Inc.	$2M	—	3.2	0.2	-504.6%	-51.3%	—	-75.7%	0.0
ENLVEnlivex Ltd.	$1.8M	0.0	—	0.0	-570.3%	—	—	63.9%	0.0
SXTP60 Degrees Pharmaceuticals, Inc.	$1.8M	—	1.6	0.7	-485.9%	73.2%	-774.8%	-310.2%	0.1
PPCBPropanc Biopharma, Inc.	$1.8M	—	—	0.2	-316.4%	—	—	-200.6%	0.0
HCWBHCW Biologics Inc.	$2.1M	—	0.3	0.3	-577.4%	709.6%	-114.0%	-75.2%	0.9
BRTXBioRestorative Therapies, Inc.	$2.1M	—	5.9	0.7	-564.8%	-8.5%	—	-365.4%	0.0
VIVSVivoSim Labs, Inc.	$2.1M	—	19.2	—	-471.7%	-21.1%	—	—	—
PPBTPurple Biotech Ltd	$2.2M	—	—	0.2	-259.6%	—	—	-272.7%	0.0
Industry median		11.7	7.7	2.2	-22.3%	12.8%	-76.9%	-60.8%	0.0
EDVA percentile		—	88th	—	7th	—	—	—	—